Gut microbiota-mediated tryptophan metabolic dysregulation in the comorbidity of inflammatory bowel disease and autism spectrum disorder: mechanisms and research progress.
Frontiers in immunology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansInflammatory Bowel DiseasesTryptophanGastrointestinal MicrobiomeAnimalsAutism Spectrum DisorderComorbidityBrainBrain-Gut Axisautism spectrum disorder (ASD)gut microbiotagut-brain axis (GBA)inflammatory bowel disease (IBD)kynureninemucosal immunityserotonin (or 5-hydroxytryptamine 5-HT)tryptophan metabolism
Come citare questo studio
Mingyu Lu, Yuxuan Chen, Hengli Zhou, Yingzhuo Lin. (2026). Gut microbiota-mediated tryptophan metabolic dysregulation in the comorbidity of inflammatory bowel disease and autism spectrum disorder: mechanisms and research progress.. Frontiers in immunology. DOI: 10.3389/fimmu.2026.1950055
Consulta la pubblicazione originale ↗